Boston Scientific Recalls HOT AXIOS Stent and Delivery System Due to Deployment Failures
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Boston Scientific Corporation is recalling 588 units of the HOT AXIOS Stent and Delivery System due to reports of deployment and expansion issues that may require surgical intervention.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 18, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Boston Scientific Corporation has initiated a voluntary recall of the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall was triggered by an increase in reports regarding stent deployment and expansion issues. According to the firm, these malfunctions can lead to procedural complications that may necessitate additional medical interventions.
Which Products Are Affected
The recall affects the following medical device:
- Product Name: HOT AXIOS Stent and Electrocautery-Enhanced Delivery System (20mm x 10mm)
- Material Number (UPN): M00553560
- UDI-DI: 8714729951100
- Recall Number: Z-1163-2026
- Quantity: 588 units
- Affected Lot Numbers: This recall includes over 200 specific lot numbers, including but not limited to: 35793920, 35952745, 35961004, 35995006, 35995007, 35995165, 36001950, 36001951, 36001952, 36001953, 36002902, and 36002903.
This product was distributed worldwide, including nationwide across the United States and Puerto Rico, as well as in over 50 other countries including Canada, Germany, Japan, and the United Kingdom.
What You Should Do
Healthcare facilities and providers should immediately identify and sequester any affected units in their inventory. Boston Scientific Corporation, located at 100 Boston Scientific Way, Marlborough, MA 01752, initiated this voluntary recall on December 19, 2025. Providers should follow the firm's instructions for the return or exchange of the affected devices.
Why This Matters
Difficulty in deploying or expanding the stent can lead to a prolongation of the medical procedure. In the most serious cases, a failure of the first flange to deploy or expand can result in a cascade of events requiring additional endoscopic or surgical intervention to remove the stent and close the puncture site.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category